R&D expenditure of CSL Ltd FY 2015-2022

Published by Statista Research Department, Apr 3, 2024
The 2022 financial year saw the research and development expenditure of Melbourne-based CSL Limited increase to over 1.1 billion U.S. dollars. CSL Limited is a global biotechnology company that is involved in the research, development, manufacturing, and marketing of products used to treat human medical conditions.

Research and development investment of CSL Limited from financial year 2015 to 2022 (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

September 2022

Region

Australia

Survey time period

financial year 2015 to 2022

Supplementary notes

Australia's financial year runs from July 1 to June 30; for example, financial year 2017 starts on July 1, 2016 and ends on June 30, 2017.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Australia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Australia

Overview

6

Prescription medication

6

Major Pharmaceuticals

5

Pharmaceutical retailers

7

Trends

7

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in AustraliaGlobal pharmaceutical industryDrug Store/Pharmacy Market in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu